Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
View ORCID ProfileHester Allen, View ORCID ProfileElise Tessier, Charlie Turner, Charlotte Anderson, Paula Blomquist, David Simons, Alessandra Løchen, Christopher I Jarvis, Natalie Groves, View ORCID ProfileFernando Capelastegui, Joe Flannagan, Asad Zaidi, Cong Chen, Christopher Rawlinson, Gareth J. Hughes, Dimple Chudasama, View ORCID ProfileSophie Nash, View ORCID ProfileSimon Thelwall, View ORCID ProfileJamie Lopez-Bernal, View ORCID ProfileGavin Dabrera, André Charlett, View ORCID ProfileMeaghan Kall, View ORCID ProfileTheresa Lamagni
doi: https://doi.org/10.1101/2022.02.15.22271001
Hester Allen
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
Elise Tessier
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
Charlie Turner
2Field Service, UK Health Security Agency, England
Charlotte Anderson
2Field Service, UK Health Security Agency, England
Paula Blomquist
2Field Service, UK Health Security Agency, England
David Simons
2Field Service, UK Health Security Agency, England
Alessandra Løchen
2Field Service, UK Health Security Agency, England
Christopher I Jarvis
2Field Service, UK Health Security Agency, England
Natalie Groves
3Genomics Cell, UK Health Security Agency, England
Fernando Capelastegui
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
Joe Flannagan
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
Asad Zaidi
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
Cong Chen
2Field Service, UK Health Security Agency, England
Christopher Rawlinson
2Field Service, UK Health Security Agency, England
Gareth J. Hughes
2Field Service, UK Health Security Agency, England
Dimple Chudasama
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
Sophie Nash
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
Simon Thelwall
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
Jamie Lopez-Bernal
4Immunisation and Countermeasures Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
Gavin Dabrera
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
André Charlett
5Statistics, Modelling and Economics Division, UK Health Security Agency, 61 Colindale Avenue, London NW9 5EQ, United Kingdom
6Joint Modelling Team, UK Health Security Agency, Porton Down, Salisbury, Wiltshire, SP4 0JG, United Kingdom
Meaghan Kall
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
Theresa Lamagni
1Epidemiology Cell, UK Health Security Agency, Wellington House, 133-155 Waterloo Road, London SE1 8UG, United Kingdom
Data Availability
Data may be available upon request.
Posted February 17, 2022.
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
Hester Allen, Elise Tessier, Charlie Turner, Charlotte Anderson, Paula Blomquist, David Simons, Alessandra Løchen, Christopher I Jarvis, Natalie Groves, Fernando Capelastegui, Joe Flannagan, Asad Zaidi, Cong Chen, Christopher Rawlinson, Gareth J. Hughes, Dimple Chudasama, Sophie Nash, Simon Thelwall, Jamie Lopez-Bernal, Gavin Dabrera, André Charlett, Meaghan Kall, Theresa Lamagni
medRxiv 2022.02.15.22271001; doi: https://doi.org/10.1101/2022.02.15.22271001
Comparative transmission of SARS-CoV-2 Omicron (B.1.1.529) and Delta (B.1.617.2) variants and the impact of vaccination: national cohort study, England
Hester Allen, Elise Tessier, Charlie Turner, Charlotte Anderson, Paula Blomquist, David Simons, Alessandra Løchen, Christopher I Jarvis, Natalie Groves, Fernando Capelastegui, Joe Flannagan, Asad Zaidi, Cong Chen, Christopher Rawlinson, Gareth J. Hughes, Dimple Chudasama, Sophie Nash, Simon Thelwall, Jamie Lopez-Bernal, Gavin Dabrera, André Charlett, Meaghan Kall, Theresa Lamagni
medRxiv 2022.02.15.22271001; doi: https://doi.org/10.1101/2022.02.15.22271001
Subject Area
Subject Areas
- Addiction Medicine (400)
- Allergy and Immunology (711)
- Anesthesia (202)
- Cardiovascular Medicine (2954)
- Dermatology (250)
- Emergency Medicine (443)
- Epidemiology (12764)
- Forensic Medicine (12)
- Gastroenterology (829)
- Genetic and Genomic Medicine (4598)
- Geriatric Medicine (420)
- Health Economics (730)
- Health Informatics (2934)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (925)
- Medical Education (427)
- Medical Ethics (116)
- Nephrology (470)
- Neurology (4373)
- Nursing (237)
- Nutrition (640)
- Oncology (2277)
- Ophthalmology (647)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (502)
- Pediatrics (1197)
- Primary Care Research (499)
- Public and Global Health (6963)
- Radiology and Imaging (1532)
- Respiratory Medicine (915)
- Rheumatology (440)
- Sports Medicine (385)
- Surgery (491)
- Toxicology (60)
- Transplantation (212)
- Urology (181)